Amino Acid Dysregulation Metabotypes Diagnostic for Autism Spectrum Disorder – AAN 2018 [PDF]
Presented at the American Association of Neurology in Los Angeles, California; April 2018
NeuroPointDX’s autism clinical study, Children’s Autism Metabolome Project (CAMP), is the largest study to identify changes in metabolism associated with autism spectrum disorder (ASD). Over 1,100 children enrolled in the study at eight clinical sites across the United States. NeuroPointDX developed a test panel for metabolic subtypes (metabotypes) associated with ASD.
Posters & Publications
- Studies have consistently shown that earlier diagnosis of #autism spectrum disorder helps kids achieve better outco… https://t.co/63zYtqetpC17 hours ago
- Eye-tracking technology helped researchers at the University of Kent gauge the reactions of adults with #autism to… https://t.co/OagWfJuLLpyesterday
- MRIs can be stressful for anyone, and they’re especially hard for patients with autism spectrum disorder. Researche… https://t.co/QyvEd0bvKT2 days ago